TY - JOUR
T1 - Type D personality is associated with depressive symptoms and clinical activity in inflammatory bowel disease
AU - the Swiss IBD Cohort Study Group
AU - Jordi, Sebastian Bruno Ulrich
AU - Botte, Federica
AU - Lang, Brian Matthew
AU - Greuter, Thomas
AU - Krupka, Niklas
AU - Auschra, Bianca
AU - Schreiner, Philipp
AU - Sulz, Michael Christian
AU - Biedermann, Luc
AU - von Känel, Roland
AU - Rogler, Gerhard
AU - Begré, Stefan
AU - Misselwitz, Benjamin
AU - Anderegg, Claudia
AU - Bauerfeind, Peter
AU - Beglinger, Christoph
AU - Belli, Dominique
AU - Bengoa, José M.
AU - Bigler, Beat
AU - Binek, Janek
AU - Blattmann, Mirjam
AU - Boehm, Stephan
AU - Borovicka, Jan
AU - Braegger, Christian P.
AU - Brunner, Nora
AU - Bühr, Patrick
AU - Burnand, Bernard
AU - Burri, Emanuel
AU - Buyse, Sophie
AU - Cremer, Matthias
AU - Criblez, Dominique H.
AU - de Saussure, Philippe
AU - Degen, Lukas
AU - Delarive, Joakim
AU - Doerig, Christopher
AU - Dora, Barbara
AU - Dorta, Gian
AU - Egger, Mara
AU - Ehmann, Tobias
AU - El-Wafa, Ali
AU - Engelmann, Matthias
AU - Ezri, Jessica
AU - Felley, Christian
AU - Fliegner, Markus
AU - Fournier, Nicolas
AU - Fraga, Montserrat
AU - Frei, Pascal
AU - Frei, Remus
AU - Fried, Michael
AU - Sauter, Bernhard
N1 - Publisher Copyright:
© 2021 John Wiley & Sons Ltd
PY - 2021/7
Y1 - 2021/7
N2 - Background: Inflammatory bowel disease (IBD) can be exacerbated by stress and depression. Type D personality, characterised by high negative affectivity and social inhibition, represents a vulnerability towards stressors and is associated with adverse outcomes in coronary heart disease. Aims: To assess the prevalence of Type D personality in IBD patients and investigate potential associations with disease course. Methods: We tested for associations between Type D (Type D Scale-14), depressive symptoms (Hospital Anxiety and Depression Scale's depression subscore ≥11) and recurrent IBD amongst Swiss IBD cohort patients. We built regression models for cross-sectional and Cox proportional hazards models for time-to-event analyses. IBD disease course was assessed by the future occurrence of active disease (Crohn's Disease Activity Index ≥150/Modified Truelove & Witts activity index ≥10) and several IBD-relevant endpoints. Results: Amongst 2275 patients (1005 ulcerative colitis, 1270 Crohn's disease), 672 (29.5%) had Type D. Type D was a significant risk factor for future active disease (adjusted hazard ratio, aHR: 1.60, corrected P value, q = 0.007) and predicted the future presence of depressive symptoms (aHR: 3.30, P < 0.001). The combination of Type D and depressive symptoms further increased the risk for active disease (aHR: 3.98, q < 0.001). However, Type D associated depressive symptoms seemed to be the main contributor to this effect as Type D's predictive power decreased considerably in models corrected for depressive symptoms (aHR: 1.32, CI: 0.97-1.79, q = 0.292). Conclusions: Type D personality's prevalence amongst IBD patients was comparable with its prevalence in the general population. Type D was strongly associated with depressive symptoms and showed modest independent associations with IBD prognosis.
AB - Background: Inflammatory bowel disease (IBD) can be exacerbated by stress and depression. Type D personality, characterised by high negative affectivity and social inhibition, represents a vulnerability towards stressors and is associated with adverse outcomes in coronary heart disease. Aims: To assess the prevalence of Type D personality in IBD patients and investigate potential associations with disease course. Methods: We tested for associations between Type D (Type D Scale-14), depressive symptoms (Hospital Anxiety and Depression Scale's depression subscore ≥11) and recurrent IBD amongst Swiss IBD cohort patients. We built regression models for cross-sectional and Cox proportional hazards models for time-to-event analyses. IBD disease course was assessed by the future occurrence of active disease (Crohn's Disease Activity Index ≥150/Modified Truelove & Witts activity index ≥10) and several IBD-relevant endpoints. Results: Amongst 2275 patients (1005 ulcerative colitis, 1270 Crohn's disease), 672 (29.5%) had Type D. Type D was a significant risk factor for future active disease (adjusted hazard ratio, aHR: 1.60, corrected P value, q = 0.007) and predicted the future presence of depressive symptoms (aHR: 3.30, P < 0.001). The combination of Type D and depressive symptoms further increased the risk for active disease (aHR: 3.98, q < 0.001). However, Type D associated depressive symptoms seemed to be the main contributor to this effect as Type D's predictive power decreased considerably in models corrected for depressive symptoms (aHR: 1.32, CI: 0.97-1.79, q = 0.292). Conclusions: Type D personality's prevalence amongst IBD patients was comparable with its prevalence in the general population. Type D was strongly associated with depressive symptoms and showed modest independent associations with IBD prognosis.
UR - http://www.scopus.com/inward/record.url?scp=85105604418&partnerID=8YFLogxK
U2 - 10.1111/apt.16365
DO - 10.1111/apt.16365
M3 - Article
C2 - 33975385
AN - SCOPUS:85105604418
SN - 0269-2813
VL - 54
SP - 53
EP - 67
JO - Alimentary Pharmacology and Therapeutics
JF - Alimentary Pharmacology and Therapeutics
IS - 1
ER -